)
Edge28 Aug 2026
Bigger, Sharper, IMAX: A Blockbuster Business
How IMAX turned an unscalable, large-screen format into the center of blockbuster filmmaking through cameras, projection, and remastering technology.
HLB
HLB (028300) investor relations material
HLB Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary14 Aug, 2026
Executive summary
Completed merger with HLB Science to consolidate R&D and optimize costs, with the surviving entity maintaining KOSDAQ listing and absorbing all business operations and assets of the dissolved entity.
The company operates in healthcare, bio, composite materials, and media commerce, with a focus on global new drug development and diagnostics.
Major restructuring included the physical spin-off of the shipbuilding business and ongoing expansion of the bio pipeline through acquisitions and licensing.
Financial highlights
2026 H1 consolidated revenue: KRW 46.7 billion; operating loss: KRW -45.7 billion; net loss: KRW -121.3 billion.
Total assets at June 2026: KRW 908 billion; equity: KRW 422 billion; liabilities: KRW 486 billion.
Gross margin for H1 2026: 46% (KRW 21.4 billion gross profit on KRW 46.7 billion revenue).
R&D expenses for H1 2026: KRW 21.7 billion (46.6% of sales).
Outlook and guidance
Focus on accelerating commercialization of key oncology assets, especially Rivoceranib and Lirafugratinib, with ongoing regulatory submissions in the US and Europe.
Strategic intent to leverage merged R&D capabilities for pipeline expansion and cost synergies.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from HLB
- Revenue up 58.8%, operating loss narrows, and focus remains on oncology drug launches.028300
Q4 2024 - Revenue up 23.6% YoY, operating loss narrows, merger boosts R&D and pipeline focus.028300Q4 2025
- Revenue fell and losses widened as R&D spending rose, with focus shifting to global drug commercialization.028300Q3 2025
- Heavy losses persist as revenue drops and R&D costs remain high; outlook hinges on drug approvals.028300Q2 2025
- Q1 2026 posted a net loss of KRW 38.0 billion amid ongoing R&D and business restructuring.028300Q1 2026
- H1 2024 saw lower revenue, ongoing losses, and a strategic focus on oncology drug approval.028300Q2 2024
- Q3 2024 saw flat sales, narrowed losses, and a strategic focus on oncology drug approval.028300Q3 2024
- Q1 2025 revenue fell to KRW 17.66B with a net loss of KRW 68.92B amid high R&D costs.028300Q1 2025
Next HLB earnings date
Q3 202613 Nov, 2026
HLB
Next HLB earnings date
Q3 202613 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage